Sex differences in cardiovascular risk profiles of ischemic stroke patients with diabetes in the Greater Cincinnati/Northern Kentucky Stroke Study: 在大辛辛那提/北 …
TE Madsen, JC Khoury, KA Alwell… - Journal of …, 2018 - Wiley Online Library
… medications prior to the stroke event were also abstracted from patient charts and categorized
into lipid-lowering medications, antihypertensive medications… and other health outcomes, …
into lipid-lowering medications, antihypertensive medications… and other health outcomes, …
伴(1.5) hours credit (0.15 CEUs) and is cosponsored
S Morri, R Treese, L Schwochert - search.proquest.com
… of lipid lowering could result in improved outcomes for … strategy compared with the use of
lipidlowering drugs; while intensive … “ While NCEP guidelines dictate the use of a lipid profile for …
lipidlowering drugs; while intensive … “ While NCEP guidelines dictate the use of a lipid profile for …
Short-and long-term effects of Xuezhikang (血脂康), an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels
… The serum PCSK9 and lipid profile were measured. The … requiring lipid-lowering drug
treatment for dyslipidemia according … (for example, clinical outcomes) of impact of XZK on PCSK9 …
treatment for dyslipidemia according … (for example, clinical outcomes) of impact of XZK on PCSK9 …
[HTML][HTML] Efficacy of Kushen decoction (苦参汤) on high-fat-diet-induced hyperlipidemia in rats
JM ZHANG, S LIANG, NIE Peng, AI Qinying… - … Chinese Medicine, 2022 - ncbi.nlm.nih.gov
… crude medicine prepared according to the method commonly used … Comparison of the gene
expression profiles in the livers from … In this study, we investigated the lipid-lowering effect of …
expression profiles in the livers from … In this study, we investigated the lipid-lowering effect of …
Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the C …
S Kannan, KM Pantalone, S Matsuda… - Journal of …, 2016 - Wiley Online Library
… medications, lipid-lowering agents, antiplatelet agents, and propensity for being on MF+SU
at baseline. Laboratory data including lipid profile … cardiovascular outcomes associated with …
at baseline. Laboratory data including lipid profile … cardiovascular outcomes associated with …
Current role of short‐term intensive insulin strategies in newly diagnosed type 2 diabetes (短期胰岛素强化治疗策略对初诊2 型糖尿病患者的作用)
W Xu, J Weng - Journal of diabetes, 2013 - Wiley Online Library
… insulin intervention had better outcomes in patients with newly … the lipid profile without using
lipid-adjusting agents could be … blockers, aspirin and lipid-lowering agents, may be more …
lipid-adjusting agents could be … blockers, aspirin and lipid-lowering agents, may be more …
Effects of Hedan Tablet (荷丹片) on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia …
R Xu, N Wu, S Li, Y Zhang, X Li, Y Guo, C Zhu… - … of integrative medicine, 2016 - Springer
… , CA, USA) according to the manufacturer's instructions as … some common prescribed
lipid-lowering drugs such as statins … of HDL subfractions on clinical outcome did not carried out …
lipid-lowering drugs such as statins … of HDL subfractions on clinical outcome did not carried out …
Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction: 对 …
… improve cardiovascular outcomes. … used to initiate or adjust lipid-lowering treatment, including
in patients with CKD. The KDIGO guidelines recommended evaluation of a full lipid profile (…
in patients with CKD. The KDIGO guidelines recommended evaluation of a full lipid profile (…
Non‐high‐density lipoprotein cholesterol: High‐density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: Results from a population …
N Zhang, X Hu, Q Zhang, P Bai, M Cai… - Journal of …, 2018 - Wiley Online Library
… diabetes and not using lipid-lowering drugs were enrolled in the … Body weight and height
were measured according to … glucose, HbA1c, and the outcome of diabetes. Multivariate linear …
were measured according to … glucose, HbA1c, and the outcome of diabetes. Multivariate linear …
Structured tool to improve clinical outcomes of type 2 diabetes mellitus patients: A randomized controlled trial: 改善2 型糖尿病患者临床结果的结构化工具: 一项随机对照 …
S Ayadurai, VB Sunderland, LBG Tee… - Journal of …, 2018 - Wiley Online Library
… outcome was significant improvement in HbA1c. Secondary outcomes were improved lipid
profiles … , antihypertensive and lipid-lowering (statin) medications prescribed at 6 months of …
profiles … , antihypertensive and lipid-lowering (statin) medications prescribed at 6 months of …